Condition
Nevi
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02385253Not ApplicableCompleted
Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance
NCT01444560Completed
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
NCT00422448Not ApplicableCompletedPrimary
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
Showing all 3 trials